S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
Log in

Addus HomeCare Stock Forecast, Price & News

+2.36 (+2.52 %)
(As of 03/8/2021 12:00 AM ET)
Today's Range
Now: $96.19
50-Day Range
MA: $116.60
52-Week Range
Now: $96.19
Volume103,395 shs
Average Volume94,398 shs
Market Capitalization$1.52 billion
P/E RatioN/A
Dividend YieldN/A
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment's services include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of June 30, 2020, the company served consumers through 190 offices located in 25 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Addus HomeCare logo


Addus HomeCare Becomes Oversold (ADUS)
March 3, 2021 |  nasdaq.com
Addus HomeCare Corp (ADUS) Q4 2020 Earnings Call Transcript
February 26, 2021 |  finance.yahoo.com
Addus HomeCare: 4Q Earnings Snapshot
February 25, 2021 |  finance.yahoo.com
Earnings Outlook For Addus HomeCare
February 24, 2021 |  benzinga.com
CVS Health's (CVS) Front Store Sales Robust, LTC Suffers
December 29, 2020 |  finance.yahoo.com
Is ADUS A Good Stock To Buy Now?
December 16, 2020 |  finance.yahoo.com
3 MedTech Growth Stocks With Solid Prospects for 2021
December 10, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Home health care services
Current SymbolNASDAQ:ADUS
Year FoundedN/A



Sales & Book Value

Annual Sales$648.79 million
Cash Flow$1.90 per share
Book Value$30.57 per share


Net Income$25.24 million


Market Cap$1.52 billion
Next Earnings Date5/3/2021 (Estimated)


Overall MarketRank

1.71 out of 5 stars

Medical Sector

227th out of 1,971 stocks

Home Health Care Services Industry

4th out of 9 stocks

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
+2.36 (+2.52 %)
(As of 03/8/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADUS News and Ratings via Email

Sign-up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Addus HomeCare (NASDAQ:ADUS) Frequently Asked Questions

Is Addus HomeCare a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Addus HomeCare stock.
View analyst ratings for Addus HomeCare
or view top-rated stocks.

What stocks does MarketBeat like better than Addus HomeCare?

Wall Street analysts have given Addus HomeCare a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Addus HomeCare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Addus HomeCare's next earnings date?

Addus HomeCare is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Addus HomeCare

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) issued its quarterly earnings data on Friday, February, 26th. The company reported $0.82 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.69 by $0.13. Addus HomeCare had a net margin of 4.65% and a trailing twelve-month return on equity of 8.90%.
View Addus HomeCare's earnings history

How has Addus HomeCare's stock price been impacted by COVID-19 (Coronavirus)?

Addus HomeCare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ADUS stock has increased by 42.2% and is now trading at $96.19.
View which stocks have been most impacted by COVID-19

What price target have analysts set for ADUS?

4 brokers have issued 12-month price targets for Addus HomeCare's stock. Their forecasts range from $98.00 to $115.00. On average, they anticipate Addus HomeCare's stock price to reach $108.60 in the next year. This suggests a possible upside of 12.9% from the stock's current price.
View analysts' price targets for Addus HomeCare
or view top-rated stocks among Wall Street analysts.

Who are Addus HomeCare's key executives?

Addus HomeCare's management team includes the following people:
  • Mr. R. Dirk Allison, CEO, Pres & Director (Age 65, Pay $1.27M)
  • Mr. Brian W. Poff, CFO, Exec. VP, Sec. & Treasurer (Age 47, Pay $705.83k)
  • Mr. Sean P. Gaffney, Exec. VP & Chief Legal Officer (Age 42, Pay $476.5k)
  • Mr. David W. Tucker, Exec. VP & Chief Devel. Officer (Age 57, Pay $373.06k)
  • Mr. Michael D. Wattenbarger, Exec. VP & Chief Information Officer (Age 50, Pay $391.11k)
  • Mr. W. Bradley Bickham, COO & Exec. VP (Age 58)
  • Ms. Monica Raines, Sr. VP & Chief Compliance Officer
  • Ms. Laurie Manning, Exec. VP & Chief Human Resource Officer (Age 66)
  • Mr. Darby Anderson, Exec. VP & Chief Strategy Officer (Age 55)
  • Ms. Diane Kumarich, Sr. VP of National Contracts & Bus. Devel.

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare CEO Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among Addus HomeCare's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Addus HomeCare's key competitors?

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and The Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.83%), Dimensional Fund Advisors LP (3.89%), Dimensional Fund Advisors LP (3.88%), Wells Fargo & Company MN (2.86%), Price T Rowe Associates Inc. MD (2.61%) and Principal Financial Group Inc. (2.58%). Company insiders that own Addus HomeCare stock include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham.
View institutional ownership trends for Addus HomeCare

Which major investors are selling Addus HomeCare stock?

ADUS stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Eaton Vance Management, Eaton Vance Management, Rothschild & Co. Asset Management US Inc., Nuveen Asset Management LLC, and Assenagon Asset Management S.A.. Company insiders that have sold Addus HomeCare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, and W Bradley Bickham.
View insider buying and selling activity for Addus HomeCare
or view top insider-selling stocks.

Which major investors are buying Addus HomeCare stock?

ADUS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Punch & Associates Investment Management Inc., First Trust Advisors LP, JPMorgan Chase & Co., EMC Capital Management, Renaissance Group LLC, and Federated Hermes Inc..
View insider buying and selling activity for Addus HomeCare
or or view top insider-buying stocks.

How do I buy shares of Addus HomeCare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $96.19.

How much money does Addus HomeCare make?

Addus HomeCare has a market capitalization of $1.52 billion and generates $648.79 million in revenue each year.

How many employees does Addus HomeCare have?

Addus HomeCare employs 5,002 workers across the globe.

What is Addus HomeCare's official website?

The official website for Addus HomeCare is www.addus.com.

Where are Addus HomeCare's headquarters?

Addus HomeCare is headquartered at 6801 GAYLORD PARKWAY, FRISCO TX, 75034.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]

This page was last updated on 3/9/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.